Sopharma AD (the “Company”) notifies that for May 2013 Sopharma AD realized an increase of sales revenues of 22 % compared to the same period of 2012, including 1% increase of domestic sales and 30% increase of export sales. During the past five months Sopharma AD recorded an increase of sales revenues of 1%, including 4% increase of domestic sales and 1% increase of export sales compared to 2012.

We would like to notify that for the month of January 2012 due to the bad weather conditions Sopharma AD realized decrease in sales revenues on annual basis of 17%, including 37% for the domestic market, 9% for the export markets.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from February 23 2012 up to and including February 29 2012 the Company bought 298 own shares representing 0.000226% of the share capital of the Company, to the total value of BGN 822.67 on the Bulgarian Stock Exchange. The average price per share was 2.76 BGN.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

SOPHARMA AD (the “Company”) hereby informs that from 9 January 2014 up to and including 15 January 2014 the Company bought 18 313 own shares representing 0.014% of the share capital of the Company, to the total value of 72 711.42 BGN on the Bulgarian Stock Exchange. The average price per share was 3.97 BGN.

The shares have been bought on the basis of decision No. 7 of the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 507 224, representing 4.17% of the share capital of the Company.

We would like to notify that for the month of February, 2012 Sopharma AD realized growth of sales revenues of 20% compared with the same month of the previous year, including 10% decrease of domestic sales 33% growth of export sales.

From the beginning of this year sales revenues increased with 3%, including 23% decrease of domestic sales and 13 % growth of export sales.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 01 March 2012 up to and including 07 March 2012 the Company bought 200 own shares representing 0.00015% of the share capital of the Company, to the total value of 570 BGN on the Bulgarian Stock Exchange. The average price per share was 2.85 BGN.

The shares have been bought on the basis of the general meeting resolution of 23.06.2010.

The intention of the Company is to use the repurchased shares in the future for the purpose of providing them to shareholders of companies targeted in mergers.

SOPHARMA AD (the “Company”) hereby informs that from 19 December 2013 up to and including 8 January 2014 the Company bought 34 045 own shares representing 0.026% of the share capital of the Company, to the total value of 133 491.80 BGN on the Bulgarian Stock Exchange. The average price per share was 3.92 BGN.

The shares have been bought on the basis of decision No. 7 of the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 488 911, representing 4.16% of the share capital of the Company.

SOPHARMA AD (the “Company”) hereby informs that from 16 January 2014 up to and including 22 January 2014 the Company bought 9 839 own shares representing 0.007% of the share capital of the Company, to the total value of 38 910.92 BGN on the Bulgarian Stock Exchange. The average price per share was 3.95 BGN.

The shares have been bought on the basis of decision No. 7 of the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 517 063, representing 4.18% of the share capital of the Company.

SOPHARMA AD (the “Company”) hereby informs that from 23 January 2014 up to and including 29 January 2014 the Company bought 5 523 own shares representing 0.004% of the share capital of the Company, to the total value of 21 825.32 BGN on the Bulgarian Stock Exchange. The average price per share was 3.95 BGN.

The shares have been bought on the basis of decision No. 7 of the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 522 586, representing 4.18% of the share capital of the Company.

We would like to notify that for the month of March, 2012 Sopharma AD realized decrease of sales revenues of 14% compared with the same month of the previous year, including 10% decrease of domestic sales and 16% decrease of export sales.

During the last two months we managed to compensate the decrease from January, caused by force major conditions and we finish the first quarter of 2012 with 3% decrease of sales revenues compared with the same quarter of 2011, including 18% decrease of domestic sales and 3% increase of export sales.